ENTITY
Immunotech Biopharm

Immunotech Biopharm (6978 HK)

15
Analysis
Health CareHong Kong
Immunotech Biopharm Ltd operates as a biopharmaceutical company. The Company develops and produces cellular immunotherapy products and other products. Immunotech Biopharm markets its products throughout China.
more
Refresh
25 Feb 2023 16:00

HSCI Index Rebalance: 35 Adds, 28 Deletes & Changes to Southbound Stock Connect

There are 35 adds & 28 deletes for the HSCI in March leading to 29 adds & 20 deletes for Stock Connect. 19 index constituents could be dropped from...

Logo
601 Views
Share
04 Jan 2023 06:29

HSCI Index Rebalance Preview and Stock Connect: A Lot of Change

We forecast 44 adds/19 deletes for the HSCI in March leading to 37 adds/deletes for Southbound Stock Connect. There could be more Connect changes...

Logo
790 Views
Share
15 Nov 2022 08:14

HSCI Index Rebalance and Stock Connect: Changes at the Margins

We see 3 inclusions for the index in Dec, and then 26 adds/16 deletions in March. Following the March rebal, we see 22 adds/37 deletions for Stock...

Logo
511 Views
Share
03 Oct 2022 05:58

HSCI Index Rebalance and Stock Connect: Potential Changes in December & March (There's a Lot!)

There could be 3 adds in December while there will be MANY more changes in March. The adds should outnumber the deletes, but there will be many...

Logo
527 Views
Share
bullishNongfu Spring
20 Feb 2022 04:23

Index Rebalance & ETF Flow Recap: HSI, HSCEI, HSTECH, HSCI, S&P/ASX, SET50, LIC, SBI Sumishin, Crown

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
455 Views
Share
x